Arkolith/Insider Trading/DNTH/Form 4

Savitz Ryan

EVP, CFO & CBODianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.2M
Net Open-Market Flow
-$3.2M
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)31K$21.77$680K31K
Jul 9, 2026Sell(S)10K$100.22$1.0M21K
Jul 9, 2026Sell(S)15K$101.24$1.6M6K
Jul 9, 2026Sell(S)6K$101.97$568K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)31K—$069K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001992324-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML